nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Rosuvastatin—atherosclerosis	0.104	0.211	CbGbCtD
Conivaptan—CYP3A4—Ezetimibe—atherosclerosis	0.104	0.211	CbGbCtD
Conivaptan—CYP3A4—Simvastatin—atherosclerosis	0.0965	0.196	CbGbCtD
Conivaptan—CYP3A4—Lovastatin—atherosclerosis	0.0945	0.192	CbGbCtD
Conivaptan—CYP3A4—Pravastatin—atherosclerosis	0.0945	0.192	CbGbCtD
Conivaptan—Atorvastatin—AHR—atherosclerosis	0.00737	0.506	CrCbGaD
Conivaptan—Atorvastatin—HMGCR—atherosclerosis	0.00718	0.494	CrCbGaD
Conivaptan—Urine output increased—Niacin—atherosclerosis	0.00405	0.0212	CcSEcCtD
Conivaptan—Atrial fibrillation—Simvastatin—atherosclerosis	0.00374	0.0195	CcSEcCtD
Conivaptan—Polyuria—Niacin—atherosclerosis	0.0037	0.0193	CcSEcCtD
Conivaptan—Atrial fibrillation—Niacin—atherosclerosis	0.00343	0.0179	CcSEcCtD
Conivaptan—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00335	0.0175	CcSEcCtD
Conivaptan—Haematuria—Rosuvastatin—atherosclerosis	0.00328	0.0171	CcSEcCtD
Conivaptan—Orthostatic hypotension—Niacin—atherosclerosis	0.00297	0.0155	CcSEcCtD
Conivaptan—Infestation NOS—Ezetimibe—atherosclerosis	0.00286	0.0149	CcSEcCtD
Conivaptan—Infestation—Ezetimibe—atherosclerosis	0.00286	0.0149	CcSEcCtD
Conivaptan—Urinary tract infection—Lovastatin—atherosclerosis	0.00284	0.0148	CcSEcCtD
Conivaptan—Mental disorder—Rosuvastatin—atherosclerosis	0.00271	0.0141	CcSEcCtD
Conivaptan—Oedema peripheral—Ezetimibe—atherosclerosis	0.00253	0.0132	CcSEcCtD
Conivaptan—Urinary tract infection—Pravastatin—atherosclerosis	0.0024	0.0125	CcSEcCtD
Conivaptan—Angiopathy—Ezetimibe—atherosclerosis	0.00233	0.0122	CcSEcCtD
Conivaptan—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00232	0.0121	CcSEcCtD
Conivaptan—Mental disorder—Ezetimibe—atherosclerosis	0.00225	0.0118	CcSEcCtD
Conivaptan—Erythema—Ezetimibe—atherosclerosis	0.00224	0.0117	CcSEcCtD
Conivaptan—Malnutrition—Ezetimibe—atherosclerosis	0.00224	0.0117	CcSEcCtD
Conivaptan—Oedema peripheral—Niacin—atherosclerosis	0.00222	0.0116	CcSEcCtD
Conivaptan—Confusional state—Rosuvastatin—atherosclerosis	0.00221	0.0116	CcSEcCtD
Conivaptan—Infection—Rosuvastatin—atherosclerosis	0.00218	0.0114	CcSEcCtD
Conivaptan—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00215	0.0112	CcSEcCtD
Conivaptan—Mental disorder—Simvastatin—atherosclerosis	0.00215	0.0112	CcSEcCtD
Conivaptan—Erythema—Simvastatin—atherosclerosis	0.00213	0.0111	CcSEcCtD
Conivaptan—Anaemia—Ezetimibe—atherosclerosis	0.00207	0.0108	CcSEcCtD
Conivaptan—Cardiac disorder—Pravastatin—atherosclerosis	0.00206	0.0107	CcSEcCtD
Conivaptan—Angiopathy—Niacin—atherosclerosis	0.00204	0.0107	CcSEcCtD
Conivaptan—Insomnia—Rosuvastatin—atherosclerosis	0.00199	0.0104	CcSEcCtD
Conivaptan—Anaemia—Simvastatin—atherosclerosis	0.00197	0.0103	CcSEcCtD
Conivaptan—Malnutrition—Niacin—atherosclerosis	0.00196	0.0102	CcSEcCtD
Conivaptan—Erythema—Niacin—atherosclerosis	0.00196	0.0102	CcSEcCtD
Conivaptan—Hypertension—Ezetimibe—atherosclerosis	0.00193	0.0101	CcSEcCtD
Conivaptan—Dry mouth—Lovastatin—atherosclerosis	0.0019	0.00991	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00189	0.00987	CcSEcCtD
Conivaptan—Pain—Rosuvastatin—atherosclerosis	0.00188	0.00981	CcSEcCtD
Conivaptan—Constipation—Rosuvastatin—atherosclerosis	0.00188	0.00981	CcSEcCtD
Conivaptan—Confusional state—Lovastatin—atherosclerosis	0.00188	0.0098	CcSEcCtD
Conivaptan—Dry mouth—Ezetimibe—atherosclerosis	0.00186	0.00972	CcSEcCtD
Conivaptan—Infection—Lovastatin—atherosclerosis	0.00185	0.00965	CcSEcCtD
Conivaptan—Confusional state—Ezetimibe—atherosclerosis	0.00184	0.00961	CcSEcCtD
Conivaptan—Infection—Ezetimibe—atherosclerosis	0.00181	0.00947	CcSEcCtD
Conivaptan—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00181	0.00945	CcSEcCtD
Conivaptan—Nervous system disorder—Ezetimibe—atherosclerosis	0.00179	0.00935	CcSEcCtD
Conivaptan—Anaemia—Pravastatin—atherosclerosis	0.00178	0.00931	CcSEcCtD
Conivaptan—Skin disorder—Ezetimibe—atherosclerosis	0.00177	0.00926	CcSEcCtD
Conivaptan—Confusional state—Simvastatin—atherosclerosis	0.00176	0.00917	CcSEcCtD
Conivaptan—Infection—Simvastatin—atherosclerosis	0.00173	0.00903	CcSEcCtD
Conivaptan—Insomnia—Lovastatin—atherosclerosis	0.00168	0.00879	CcSEcCtD
Conivaptan—Hypertension—Pravastatin—atherosclerosis	0.00167	0.00869	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00166	0.00865	CcSEcCtD
Conivaptan—Insomnia—Ezetimibe—atherosclerosis	0.00165	0.00862	CcSEcCtD
Conivaptan—Dry mouth—Niacin—atherosclerosis	0.00163	0.00852	CcSEcCtD
Conivaptan—Pain—Lovastatin—atherosclerosis	0.00159	0.00831	CcSEcCtD
Conivaptan—Constipation—Lovastatin—atherosclerosis	0.00159	0.00831	CcSEcCtD
Conivaptan—Confusional state—Pravastatin—atherosclerosis	0.00159	0.00829	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00158	0.00823	CcSEcCtD
Conivaptan—Insomnia—Simvastatin—atherosclerosis	0.00157	0.00822	CcSEcCtD
Conivaptan—Infection—Pravastatin—atherosclerosis	0.00156	0.00816	CcSEcCtD
Conivaptan—Pain—Ezetimibe—atherosclerosis	0.00156	0.00815	CcSEcCtD
Conivaptan—Constipation—Ezetimibe—atherosclerosis	0.00156	0.00815	CcSEcCtD
Conivaptan—Pruritus—Rosuvastatin—atherosclerosis	0.00155	0.00811	CcSEcCtD
Conivaptan—Skin disorder—Niacin—atherosclerosis	0.00155	0.00811	CcSEcCtD
Conivaptan—Feeling abnormal—Lovastatin—atherosclerosis	0.00153	0.00801	CcSEcCtD
Conivaptan—Feeling abnormal—Ezetimibe—atherosclerosis	0.0015	0.00785	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.0015	0.00785	CcSEcCtD
Conivaptan—Diarrhoea—Rosuvastatin—atherosclerosis	0.0015	0.00785	CcSEcCtD
Conivaptan—Hypotension—Niacin—atherosclerosis	0.00149	0.0078	CcSEcCtD
Conivaptan—Constipation—Simvastatin—atherosclerosis	0.00149	0.00777	CcSEcCtD
Conivaptan—Pain—Simvastatin—atherosclerosis	0.00149	0.00777	CcSEcCtD
Conivaptan—Body temperature increased—Lovastatin—atherosclerosis	0.00147	0.00768	CcSEcCtD
Conivaptan—Insomnia—Niacin—atherosclerosis	0.00145	0.00755	CcSEcCtD
Conivaptan—Body temperature increased—Ezetimibe—atherosclerosis	0.00144	0.00754	CcSEcCtD
Conivaptan—Feeling abnormal—Simvastatin—atherosclerosis	0.00143	0.00749	CcSEcCtD
Conivaptan—Insomnia—Pravastatin—atherosclerosis	0.00142	0.00743	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Niacin—atherosclerosis	0.00138	0.00721	CcSEcCtD
Conivaptan—Body temperature increased—Simvastatin—atherosclerosis	0.00138	0.00719	CcSEcCtD
Conivaptan—Headache—Rosuvastatin—atherosclerosis	0.00138	0.00718	CcSEcCtD
Conivaptan—Pain—Niacin—atherosclerosis	0.00137	0.00714	CcSEcCtD
Conivaptan—Constipation—Pravastatin—atherosclerosis	0.00135	0.00703	CcSEcCtD
Conivaptan—Pain—Pravastatin—atherosclerosis	0.00135	0.00703	CcSEcCtD
Conivaptan—Pruritus—Lovastatin—atherosclerosis	0.00132	0.00688	CcSEcCtD
Conivaptan—Nausea—Rosuvastatin—atherosclerosis	0.0013	0.00681	CcSEcCtD
Conivaptan—Feeling abnormal—Pravastatin—atherosclerosis	0.0013	0.00677	CcSEcCtD
Conivaptan—Pruritus—Ezetimibe—atherosclerosis	0.00129	0.00674	CcSEcCtD
Conivaptan—Diarrhoea—Lovastatin—atherosclerosis	0.00127	0.00665	CcSEcCtD
Conivaptan—Body temperature increased—Niacin—atherosclerosis	0.00126	0.0066	CcSEcCtD
Conivaptan—Diarrhoea—Ezetimibe—atherosclerosis	0.00125	0.00652	CcSEcCtD
Conivaptan—Body temperature increased—Pravastatin—atherosclerosis	0.00124	0.0065	CcSEcCtD
Conivaptan—Pruritus—Simvastatin—atherosclerosis	0.00123	0.00643	CcSEcCtD
Conivaptan—Diarrhoea—Simvastatin—atherosclerosis	0.00119	0.00622	CcSEcCtD
Conivaptan—Vomiting—Lovastatin—atherosclerosis	0.00118	0.00618	CcSEcCtD
Conivaptan—Headache—Lovastatin—atherosclerosis	0.00117	0.00609	CcSEcCtD
Conivaptan—Vomiting—Ezetimibe—atherosclerosis	0.00116	0.00606	CcSEcCtD
Conivaptan—Headache—Ezetimibe—atherosclerosis	0.00114	0.00597	CcSEcCtD
Conivaptan—Pruritus—Niacin—atherosclerosis	0.00113	0.00591	CcSEcCtD
Conivaptan—Pruritus—Pravastatin—atherosclerosis	0.00111	0.00581	CcSEcCtD
Conivaptan—Vomiting—Simvastatin—atherosclerosis	0.00111	0.00578	CcSEcCtD
Conivaptan—Nausea—Lovastatin—atherosclerosis	0.00111	0.00577	CcSEcCtD
Conivaptan—Diarrhoea—Niacin—atherosclerosis	0.00109	0.00571	CcSEcCtD
Conivaptan—Headache—Simvastatin—atherosclerosis	0.00109	0.00569	CcSEcCtD
Conivaptan—Nausea—Ezetimibe—atherosclerosis	0.00108	0.00566	CcSEcCtD
Conivaptan—Diarrhoea—Pravastatin—atherosclerosis	0.00108	0.00562	CcSEcCtD
Conivaptan—Nausea—Simvastatin—atherosclerosis	0.00103	0.0054	CcSEcCtD
Conivaptan—Vomiting—Niacin—atherosclerosis	0.00102	0.00531	CcSEcCtD
Conivaptan—Headache—Niacin—atherosclerosis	0.001	0.00523	CcSEcCtD
Conivaptan—Vomiting—Pravastatin—atherosclerosis	0.001	0.00523	CcSEcCtD
Conivaptan—Headache—Pravastatin—atherosclerosis	0.000986	0.00515	CcSEcCtD
Conivaptan—Nausea—Niacin—atherosclerosis	0.00095	0.00496	CcSEcCtD
Conivaptan—Nausea—Pravastatin—atherosclerosis	0.000935	0.00488	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—HRH1—atherosclerosis	0.000528	0.00175	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CNR2—atherosclerosis	0.000517	0.00172	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CNR2—atherosclerosis	0.000513	0.00171	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000507	0.00168	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000503	0.00167	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000499	0.00166	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—AGT—atherosclerosis	0.000469	0.00156	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—AGT—atherosclerosis	0.000465	0.00155	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.00046	0.00153	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL3—atherosclerosis	0.000444	0.00148	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000443	0.00147	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCR2—atherosclerosis	0.000443	0.00147	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL3—atherosclerosis	0.000441	0.00147	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000441	0.00147	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000439	0.00146	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCR2—atherosclerosis	0.000439	0.00146	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000437	0.00145	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—F2—atherosclerosis	0.000433	0.00144	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—GHRL—atherosclerosis	0.000431	0.00143	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—F2—atherosclerosis	0.00043	0.00143	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GHRL—atherosclerosis	0.000428	0.00142	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOA4—atherosclerosis	0.000417	0.00139	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000416	0.00138	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOA4—atherosclerosis	0.000414	0.00138	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCR2—atherosclerosis	0.000402	0.00134	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EDNRA—atherosclerosis	0.000402	0.00134	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000401	0.00133	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCR2—atherosclerosis	0.000399	0.00133	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EDNRA—atherosclerosis	0.000399	0.00133	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000398	0.00132	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GHRL—atherosclerosis	0.000392	0.0013	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GHRL—atherosclerosis	0.000389	0.00129	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCL2—atherosclerosis	0.000386	0.00128	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL4—atherosclerosis	0.000384	0.00128	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL2—atherosclerosis	0.000383	0.00127	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL4—atherosclerosis	0.000382	0.00127	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—KNG1—atherosclerosis	0.000379	0.00126	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000376	0.00125	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—KNG1—atherosclerosis	0.000376	0.00125	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000374	0.00124	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000372	0.00124	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000361	0.0012	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOA2—atherosclerosis	0.000359	0.00119	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOA2—atherosclerosis	0.000356	0.00118	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000349	0.00116	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—KNG1—atherosclerosis	0.000344	0.00114	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—UTS2—atherosclerosis	0.000343	0.00114	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AGTR1—atherosclerosis	0.000342	0.00114	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—KNG1—atherosclerosis	0.000341	0.00113	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—UTS2—atherosclerosis	0.00034	0.00113	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AGTR1—atherosclerosis	0.000339	0.00113	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000334	0.00111	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000329	0.00109	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASR—atherosclerosis	0.000328	0.00109	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CX3CR1—atherosclerosis	0.000328	0.00109	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CX3CR1—atherosclerosis	0.000326	0.00108	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASR—atherosclerosis	0.000326	0.00108	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CX3CL1—atherosclerosis	0.000322	0.00107	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CX3CL1—atherosclerosis	0.00032	0.00106	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—EDN1—atherosclerosis	0.000319	0.00106	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—EDN1—atherosclerosis	0.000317	0.00105	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCL5—atherosclerosis	0.000317	0.00105	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCL5—atherosclerosis	0.000314	0.00104	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000309	0.00103	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CNR2—atherosclerosis	0.000305	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CXCL8—atherosclerosis	0.000305	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MMP3—atherosclerosis	0.000305	0.00101	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000304	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000304	0.00101	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CNR2—atherosclerosis	0.000303	0.00101	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CXCL8—atherosclerosis	0.000303	0.00101	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MMP3—atherosclerosis	0.000302	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000301	0.001	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000299	0.000993	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EDN1—atherosclerosis	0.00029	0.000963	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EDN1—atherosclerosis	0.000288	0.000956	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL5—atherosclerosis	0.000287	0.000956	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL5—atherosclerosis	0.000285	0.000949	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000276	0.000919	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PRKCG—atherosclerosis	0.000273	0.000909	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VWF—atherosclerosis	0.000272	0.000905	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PRKCG—atherosclerosis	0.000271	0.000902	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOC3—atherosclerosis	0.00027	0.000899	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VWF—atherosclerosis	0.00027	0.000898	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LDLR—atherosclerosis	0.000269	0.000893	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOC3—atherosclerosis	0.000268	0.000892	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LDLR—atherosclerosis	0.000267	0.000887	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AGT—atherosclerosis	0.000265	0.00088	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AGT—atherosclerosis	0.000263	0.000874	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL3—atherosclerosis	0.000263	0.000873	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL3—atherosclerosis	0.000261	0.000866	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NCF1—atherosclerosis	0.000251	0.000836	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NCF1—atherosclerosis	0.00025	0.00083	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—F2—atherosclerosis	0.000245	0.000813	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—F2—atherosclerosis	0.000243	0.000808	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AGT—atherosclerosis	0.00024	0.000799	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AGT—atherosclerosis	0.000239	0.000794	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCR2—atherosclerosis	0.000237	0.000789	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDNRA—atherosclerosis	0.000237	0.000789	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CYBA—atherosclerosis	0.000236	0.000786	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR2—atherosclerosis	0.000236	0.000784	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDNRA—atherosclerosis	0.000236	0.000784	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CYBA—atherosclerosis	0.000235	0.00078	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000234	0.000778	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000232	0.000773	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GHRL—atherosclerosis	0.000231	0.000769	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PARP1—atherosclerosis	0.000231	0.000769	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLAT—atherosclerosis	0.000231	0.000769	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLAT—atherosclerosis	0.00023	0.000764	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PARP1—atherosclerosis	0.00023	0.000764	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GHRL—atherosclerosis	0.00023	0.000764	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—F2—atherosclerosis	0.000222	0.000739	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—F2—atherosclerosis	0.000221	0.000733	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000213	0.000707	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000211	0.000702	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KNG1—atherosclerosis	0.000203	0.000675	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGTR1—atherosclerosis	0.000202	0.000671	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KNG1—atherosclerosis	0.000202	0.00067	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGTR1—atherosclerosis	0.0002	0.000666	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL2—atherosclerosis	0.000198	0.000658	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLG—atherosclerosis	0.000197	0.000654	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL2—atherosclerosis	0.000197	0.000654	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLG—atherosclerosis	0.000195	0.000649	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SOCS3—atherosclerosis	0.000186	0.000619	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SOCS3—atherosclerosis	0.000185	0.000615	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP3—atherosclerosis	0.00018	0.000598	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF2—atherosclerosis	0.000179	0.000595	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP3—atherosclerosis	0.000179	0.000594	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF2—atherosclerosis	0.000178	0.000591	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOB—atherosclerosis	0.000174	0.000578	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOB—atherosclerosis	0.000173	0.000574	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000172	0.000573	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000171	0.000569	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDN1—atherosclerosis	0.000171	0.000569	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDN1—atherosclerosis	0.00017	0.000565	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL5—atherosclerosis	0.00017	0.000565	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL5—atherosclerosis	0.000169	0.00056	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LPL—atherosclerosis	0.000166	0.000552	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LPL—atherosclerosis	0.000165	0.000548	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCG—atherosclerosis	0.000161	0.000537	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCG—atherosclerosis	0.00016	0.000533	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SPP1—atherosclerosis	0.000157	0.000523	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL8—atherosclerosis	0.000157	0.00052	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SPP1—atherosclerosis	0.000156	0.000519	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL8—atherosclerosis	0.000155	0.000517	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDGFB—atherosclerosis	0.000146	0.000484	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDGFB—atherosclerosis	0.000144	0.00048	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGT—atherosclerosis	0.000142	0.000472	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGT—atherosclerosis	0.000141	0.000469	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—atherosclerosis	0.000139	0.000463	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—atherosclerosis	0.000139	0.000463	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—atherosclerosis	0.000138	0.000459	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—atherosclerosis	0.000138	0.000459	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CAV1—atherosclerosis	0.000138	0.000458	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	0.000138	0.000458	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOA1—atherosclerosis	0.000138	0.000457	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CAV1—atherosclerosis	0.000137	0.000455	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOA1—atherosclerosis	0.000137	0.000454	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	0.000136	0.000452	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ESR1—atherosclerosis	0.000133	0.000442	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ESR1—atherosclerosis	0.000132	0.000439	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—F2—atherosclerosis	0.000131	0.000436	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—F2—atherosclerosis	0.00013	0.000433	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CG—atherosclerosis	0.000126	0.000418	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CG—atherosclerosis	0.000125	0.000415	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAPK3—atherosclerosis	0.00012	0.0004	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAPK3—atherosclerosis	0.000119	0.000397	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—INS—atherosclerosis	0.000119	0.000395	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—INS—atherosclerosis	0.000118	0.000392	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—atherosclerosis	0.000117	0.000389	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—atherosclerosis	0.000116	0.000386	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—atherosclerosis	0.000115	0.000382	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—atherosclerosis	0.000114	0.00038	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—atherosclerosis	0.000109	0.000363	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—atherosclerosis	0.000108	0.00036	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—atherosclerosis	0.000104	0.000347	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—atherosclerosis	0.000104	0.000344	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	9.77e-05	0.000325	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL8—atherosclerosis	9.25e-05	0.000307	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLTP—atherosclerosis	9.19e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL8—atherosclerosis	9.18e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—atherosclerosis	8.93e-05	0.000297	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—atherosclerosis	8.87e-05	0.000295	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—atherosclerosis	8.79e-05	0.000292	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—atherosclerosis	8.73e-05	0.00029	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—atherosclerosis	8.37e-05	0.000278	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—atherosclerosis	8.31e-05	0.000276	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKB1—atherosclerosis	8.28e-05	0.000275	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKB1—atherosclerosis	8.22e-05	0.000273	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK8—atherosclerosis	8.14e-05	0.00027	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—atherosclerosis	8.11e-05	0.00027	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK8—atherosclerosis	8.08e-05	0.000269	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—atherosclerosis	8.06e-05	0.000268	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LTA4H—atherosclerosis	7.97e-05	0.000265	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCG8—atherosclerosis	7.97e-05	0.000265	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—atherosclerosis	7.51e-05	0.00025	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—atherosclerosis	7.46e-05	0.000248	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT3—atherosclerosis	7.44e-05	0.000247	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT3—atherosclerosis	7.38e-05	0.000245	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK3—atherosclerosis	7.11e-05	0.000236	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK3—atherosclerosis	7.06e-05	0.000235	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—atherosclerosis	6.89e-05	0.000229	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—atherosclerosis	6.85e-05	0.000228	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCG1—atherosclerosis	6.3e-05	0.000209	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FABP4—atherosclerosis	5.92e-05	0.000197	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LCAT—atherosclerosis	5.92e-05	0.000197	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA4—atherosclerosis	5.81e-05	0.000193	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.71e-05	0.00019	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP27A1—atherosclerosis	5.28e-05	0.000175	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—atherosclerosis	5.2e-05	0.000173	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—atherosclerosis	5.16e-05	0.000171	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALOX15—atherosclerosis	5e-05	0.000166	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5e-05	0.000166	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5e-05	0.000166	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA2—atherosclerosis	5e-05	0.000166	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.94e-05	0.000164	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—atherosclerosis	4.79e-05	0.000159	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPA—atherosclerosis	4.77e-05	0.000159	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—atherosclerosis	4.76e-05	0.000158	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—BGN—atherosclerosis	4.62e-05	0.000154	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA5—atherosclerosis	4.58e-05	0.000152	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.4e-05	0.000146	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.25e-05	0.000141	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.82e-05	0.000127	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LIPC—atherosclerosis	3.79e-05	0.000126	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOC3—atherosclerosis	3.77e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LDLR—atherosclerosis	3.75e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CETP—atherosclerosis	3.66e-05	0.000122	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.5e-05	0.000116	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.31e-05	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.95e-05	9.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.53e-05	8.41e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOB—atherosclerosis	2.42e-05	8.06e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.36e-05	7.84e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPL—atherosclerosis	2.31e-05	7.69e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX1—atherosclerosis	2.26e-05	7.5e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CD36—atherosclerosis	2.2e-05	7.31e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.08e-05	6.93e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARA—atherosclerosis	2.04e-05	6.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AGT—atherosclerosis	1.98e-05	6.58e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—atherosclerosis	1.94e-05	6.45e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAV1—atherosclerosis	1.92e-05	6.39e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA1—atherosclerosis	1.92e-05	6.37e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.75e-05	5.82e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—atherosclerosis	1.69e-05	5.62e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INS—atherosclerosis	1.66e-05	5.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—atherosclerosis	1.52e-05	5.05e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—atherosclerosis	1.45e-05	4.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.33e-05	4.42e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—atherosclerosis	6.68e-06	2.22e-05	CbGpPWpGaD
